Are There Already Use Cases for Patient Identified Data?

It's really valuable in the rare disease space and highly motivated small populations of patients that face very, very complicated journeys. And we partner with companies that do bring consented information in because we believe that those pathways are important. We love supporting them because we see that already starting to change the practice of how companies think about consent to data.